Online Mendelian Inheritance in Man (OMIM) (original) (raw)

  1. Arnett, H. A., Fancy, S. P. J., Alberta, J. A., Zhao, C., Plant, S. R., Kaing, S., Raine, C. S., Rowitch, D. H., Franklin, R. J. M., Stiles, C. D.bHLH transcription factor Olig1 is required to repair demyelinated lesions in the CNS. Science 306: 2111-2115, 2004. [PubMed: 15604411] [Full Text: https://doi.org/10.1126/science.1103709\]
  2. Australia and New Zealand Multiple Sclerosis Genetics Consortium ANZgene.Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nature Genet. 41: 824-828, 2009. [PubMed: 19525955] [Full Text: https://doi.org/10.1038/ng.396\]
  3. Balashov, K. E., Aung, L. L., Vaknin-Dembinsky, A., Dhib-Jalbut, S., Weiner, H. L.Interferon-beta inhibits toll-like receptor 9 processing in multiple sclerosis. Ann. Neurol. 68: 899-906, 2010. [PubMed: 21061396] [Full Text: https://doi.org/10.1002/ana.22136\]
  4. Ban, M., Caillier, S., Mero, I.-L., Myhr, K.-M., Celius, E. G., Aarseth, J., Torkildsen, O., Harbo, H. F., Oksenberg, J., Hauser, S. L., Sawcer, S., Compston, A.No evidence of association between mutant alleles of the CYP27B1 gene and multiple sclerosis. Ann. Neurol. 73: 430-432, 2013. [PubMed: 23444327] [Full Text: https://doi.org/10.1002/ana.23833\]
  5. Ban, M., Goris, A., Lorentzen, A. R., Baker, A., Mihalova, T., Ingram, G., Booth, D. R., Heard, R. N., Stewart, G. J., Bogaert, E., Dubois, B., Harbo, H. F., and 19 others.Replication analysis identifies TYK2 as a multiple sclerosis susceptibility factor. Europ. J. Hum. Genet. 17: 1309-1313, 2009. [PubMed: 19293837] [Full Text: https://doi.org/10.1038/ejhg.2009.41\]
  6. Baranzini, S. E., Mudge, J., van Velkinburgh, J. C., Khankhanian, P., Khrebtukova, I., Miller, N. A., Zhang, L., Farmer, A. D., Bell, C. J., Kim, R. W., May, G. D., Woodward, J. E., and 17 others.Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis. Nature 464: 1351-1356, 2010. [PubMed: 20428171] [Full Text: https://doi.org/10.1038/nature08990\]
  7. Baranzini, S. E., Wang, J., Gibson, R. A., Galwey, N., Naegelin, Y., Barkhof, F., Radue, E.-W., Lindberg, R. L. P., Uitdehaag, B. M. G., Johnson, M. R., Angelakopoulou, A., Hall, L., and 25 others.Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Hum. Molec. Genet. 18: 767-778, 2009. [PubMed: 19010793] [Full Text: https://doi.org/10.1093/hmg/ddn388\]
  8. Barcellos, L. F., Caillier, S., Dragone, L., Elder, M., Vittinghoff, E., Bucher, P., Lincoln, R. R., Pericak-Vance, M., Haines, J. L., Weiss, A., Hauser, S. L., Oksenberg, J. R.PTPRC (CD45) is not associated with the development of multiple sclerosis in U.S. patients. Nature Genet. 29: 23-24, 2001. [PubMed: 11528386] [Full Text: https://doi.org/10.1038/ng722\]
  9. Barcellos, L. F., Oksenberg, J. R., Begovich, A. B., Martin, E. R., Schmidt, S., Vittinghoff, E., Goodin, D. S., Pelletier, D., Lincoln, R. R., Bucher, P., Swerdlin, A., Pericak-Vance, M. A., Haines, J. L., Hauser, S. L.HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course. Am. J. Hum. Genet. 72: 710-716, 2003. [PubMed: 12557126] [Full Text: https://doi.org/10.1086/367781\]
  10. Barcellos, L. F., Schito, A. M., Rimmler, J. B., Vittinghoff, E., Shih, A., Lincoln, R., Callier, S., Elkins, M. K., Goodkin, D. E., Haines, J. L., Pericak-Vance, M. A., Hauser, S. L., Oksenberg, J. R.CC-chemokine receptor 5 polymorphism and age of onset in familial multiple sclerosis. Immunogenetics 51: 281-288, 2000. [PubMed: 10803840] [Full Text: https://doi.org/10.1007/s002510050621\]
  11. Barizzone, N., Pauwels, I., Luciano, B., Franckaert, D., Guerini, F. R., Cosemans, L., Hilven, K., Salviati, A., Dooley, J., Danso-Abeam, D., di Sapio, A., Cavalla, P., Decallonne, B., Mathieu, C., Liston, A., Leone, M., Dubois, B., D'Alfonso, S., Goris, A.No evidence for a role of rare CYP27B1 functional variations in multiple sclerosis. Ann. Neurol. 73: 433-437, 2013. [PubMed: 23483640] [Full Text: https://doi.org/10.1002/ana.23834\]
  12. Bartholomaus, I., Kawakami, N., Odoardi, F., Schlager, C., Miljkovic, D., Ellwart, J. W., Klinkert, W. E. F., Flugel-Koch, C., Issekutz, T. B., Wekerle, H., Flugel, A.Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions. Nature 462: 94-98, 2009. [PubMed: 19829296] [Full Text: https://doi.org/10.1038/nature08478\]
  13. Bas, H.Sclerosis multiplex familiaris. Z. Arztl. Fortbild. (Jena) 58: 153-155, 1964. [PubMed: 14151717]
  14. Beall, S. S., Concannon, P., Charmley, P., McFarland, H. F., Gatti, R. A., Hood, L. E., McFarlin, D. E., Biddison, W. E.The germline repertoire of T cell receptor beta-chain genes in patients with chronic progressive multiple sclerosis. J. Neuroimmun. 21: 59-66, 1989. [PubMed: 2562801] [Full Text: https://doi.org/10.1016/0165-5728(89)90159-8\]
  15. Bell, J. I., Lathrop, G. M.Multiple loci for multiple sclerosis. Nature Genet. 13: 377-378, 1996. [PubMed: 8696322] [Full Text: https://doi.org/10.1038/ng0896-377\]
  16. Beraud, E., Viola, A., Regaya, I., Confort-Gouny, S., Siaud, P., Ibarrola, D., Le Fur, Y., Barbaria, J., Pellissier, J.-F., Sabatier, J.-M., Medina, I., Cozzone, P. J.Block of neural Kv1.1 potassium channels for neuroinflammatory disease therapy. Ann. Neurol. 60: 586-596, 2006. [PubMed: 17044011] [Full Text: https://doi.org/10.1002/ana.21007\]
  17. Berer, K., Mues, M., Koutrolos, M., Al Rasbi, Z., Boziki, M., Johner, C., Wekerle, H., Krishnamoorthy, G.Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature 479: 538-541, 2011. [PubMed: 22031325] [Full Text: https://doi.org/10.1038/nature10554\]
  18. Bird, T. D.Apparent familial multiple sclerosis in three generations: report of a family with histocompatibility antigen typing. Arch. Neurol. 32: 414-416, 1975. [PubMed: 1131074] [Full Text: https://doi.org/10.1001/archneur.1975.00490480080009\]
  19. Bittner, S., Bobak, N., Herrmann, A. M., Gobel, K., Meuth, P., Hohn, K. G., Stenner, M.-P., Budde, T., Wiendl, H., Meuth, S. G.Upregulation of K(2P)5.1 potassium channels in multiple sclerosis. Ann. Neurol. 68: 58-69, 2010. [PubMed: 20582984] [Full Text: https://doi.org/10.1002/ana.22010\]
  20. Bomprezzi, R., Ringner, M., Kim, S., Bittner, M. L., Khan, J., Chen, Y. Elkahloun, A., Yu, A., Bielekova, B., Meltzer, P. S., Martin, R., McFarland, H. F., Trent, J. M.Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to disease. Hum. Molec. Genet. 12: 2191-2199, 2003. [PubMed: 12915464] [Full Text: https://doi.org/10.1093/hmg/ddg221\]
  21. Butzkueven, H., Zhang, J.-G., Soilu-Hanninen, M., Hochrein, H., Chionh, F., Shipham, K. A., Emery, B., Turnley, A. M., Petratos, S., Ernst, M., Bartlett, P. F., Kilpatrick, T. J.LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival. Nature Med. 8: 613-619, 2002. [PubMed: 12042813] [Full Text: https://doi.org/10.1038/nm0602-613\]
  22. Chabas, D., Baranzini, S. E., Mitchell, D., Bernard, C. C. A., Rittling, S. R., Denhardt, D. T., Sobel, R. A., Lock, C., Karpuj, M., Pedotti, R., Heller, R., Oksenberg, J. R., Steinman, L.The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science 294: 1731-1735, 2001. [PubMed: 11721059] [Full Text: https://doi.org/10.1126/science.1062960\]
  23. Chao, M. J., Ramagopalan, S. V., Herrera, B. M., Lincoln, M. R., Dyment, D. A., Sadovnick, A. D., Ebers, G. C.Epigenetics in multiple sclerosis susceptibility: difference in transgenerational risk localizes to the major histocompatibility complex. Hum. Molec. Genet. 18: 261-266, 2009. [PubMed: 19098025] [Full Text: https://doi.org/10.1093/hmg/ddn353\]
  24. Chapman, J., Korczyn, A. D, Karussis, D. M., Michaelson, D. M.The effects of APOE genotype on age at onset and progression of neurodegenerative diseases. Neurology 57: 1482-1485, 2001. [PubMed: 11673593] [Full Text: https://doi.org/10.1212/wnl.57.8.1482\]
  25. Chapman, J., Vinokurov, S., Achiron, A., Karussis, D. M., Mitosek-Szewczyk, K., Birnbaum, M., Michaelson, D. M., Korczyn, A. D.APOE genotype is a major predictor of long-term progression of disability in MS. Neurology 56: 312-316, 2001. [PubMed: 11171894] [Full Text: https://doi.org/10.1212/wnl.56.3.312\]
  26. Charmley, P., Beall, S. S., Concannon, P., Hood, L., Gatti, R. A.Further localization of a multiple sclerosis susceptibility gene on chromosome 7q using a new T cell receptor beta-chain DNA polymorphism. J. Neuroimmun. 32: 231-240, 1991. [PubMed: 1674514] [Full Text: https://doi.org/10.1016/0165-5728(91)90193-b\]
  27. Chataway, J., Feakes, R., Coraddu, F., Gray, J., Deans, J., Fraser, M., Robertson, N., Broadley, S., Jones, H., Clayton, D., Goodfellow, P., Sawcer, S., Compston, A.The genetics of multiple sclerosis: principles, background and updated results of the United Kingdom systematic genome screen. Brain 121: 1869-1887, 1998. [PubMed: 9798743] [Full Text: https://doi.org/10.1093/brain/121.10.1869\]
  28. Chen, Y., Langrish, C. L., Mckenzie, B., Joyce-Shaikh, B., Stumhofer, J. S., McClanahan, T., Blumenschein, W., Churakovsa, T., Low, J., Presta, L., Hunter, C. A., Kastelein, R. A., Cua, D. J.Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. J. Clin. Invest. 116: 1317-1326, 2006. [PubMed: 16670771] [Full Text: https://doi.org/10.1172/JCI25308\]
  29. Cocco, E., Murru, M. R., Melis, C., Schirru, L., Solla, E., Lai, M., Rolesu, M., Marrosu, M. G.PTPRC (CD45) C77G mutation does not contribute to multiple sclerosis susceptibility in Sardinian patients. J. Neurol. 251: 1085-1088, 2004. [PubMed: 15372250] [Full Text: https://doi.org/10.1007/s00415-004-0485-1\]
  30. Colover, J.Genetic susceptibility to multiple sclerosis linked to myelin basic protein gene. Lancet 341: 56, 1993. [PubMed: 7678049] [Full Text: https://doi.org/10.1016/0140-6736(93)92534-z\]
  31. Comabella, M., Craig, D. W., Morcillo-Suarez, C., Rio, J., Navarro, A., Fernandez, M., Martin, R., Montalban, X.Genome-wide scan of 500,000 single-nucleotide polymorphisms among responders and nonresponders to interferon beta therapy in multiple sclerosis. Arch. Neurol. 66: 972-978, 2009. [PubMed: 19667218] [Full Text: https://doi.org/10.1001/archneurol.2009.150\]
  32. Coraddu, F., Sawcer, S., D'Alfonso, S., Lai, M., Hensiek, A., Solla, E., Broadley, S., Mancosu, C., Pugliatti, M., Marrosu, M. G., Compston, A.A genome screen for multiple sclerosis in Sardinian multiplex families. Europ. J. Hum. Genet. 9: 621-626, 2001. [PubMed: 11528508] [Full Text: https://doi.org/10.1038/sj.ejhg.5200680\]
  33. Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., Zurawski, S., Wiekowski, M., Lira, S. A., Gorman, D., Kastelein, R. A., Sedgwick, J. D.Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421: 744-748, 2003. [PubMed: 12610626] [Full Text: https://doi.org/10.1038/nature01355\]
  34. D'Netto, M. J., Ward, H., Morrison, K. M., Ramagopalan, S. V., Dyment, D. A., DeLuca, G. C., Handunnetthi, L., Sadovnick, A. D., Ebers, G. C.Risk alleles for multiple sclerosis in multiplex families. Neurology 72: 1984-1988, 2009. [PubMed: 19506219] [Full Text: https://doi.org/10.1212/WNL.0b013e3181a92c25\]
  35. De Jager, P. L., Baecher-Allan, C., Maier, L. M., Arthur, A. T., Ottoboni, L., Barcellos, L., McCauley, J. L., Sawcer, S., Goris, A., Saarela, J., Yelensky, R., Price, A., and 26 others.The role of the CD58 locus in multiple sclerosis. Proc. Nat. Acad. Sci. 106: 5264-5269, 2009. [PubMed: 19237575] [Full Text: https://doi.org/10.1073/pnas.0813310106\]
  36. De Jager, P. L., Jia, X., Wang, J., de Bakker, P. I. W., Ottoboni, L., Aggarwal, N. T., Picco, L., Raychaudhuri, S., Tran, D., Aubin, C., Briskin, R., Romano, S., and 22 others.Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nature Genet. 41: 776-782, 2009. [PubMed: 19525953] [Full Text: https://doi.org/10.1038/ng.401\]
  37. Del Boccio, P., Pieragostino, D., Lugaresi, A., Di Ioia, M., Pavone, B., Travaglini, D., D'Aguanno, S., Bernardini, S., Sacchetta, P., Federici, G., Di Ilio, C., Gambi, D., Urbani, A.Cleavage of cystatin C is not associated with multiple sclerosis. Ann. Neurol. 62: 201-204, 2007. [PubMed: 17006926] [Full Text: https://doi.org/10.1002/ana.20968\]
  38. DeLuca, G. C., Ramagopalan, S. V., Herrera, B. M., Dyment, D. A., Lincoln, M. R., Montpetit, A., Pugliatti, M., Barnardo, M. C. N., Risch, N. J., Sadovnick, A. D., Chao, M., Sotgiu, S., Hudson, T. J., Ebers, G. C.An extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA-DRB1 locus. Proc. Nat. Acad. Sci. 104: 20896-20901, 2007. [PubMed: 18087043] [Full Text: https://doi.org/10.1073/pnas.0707731105\]
  39. Derfuss, T., Parikh, K., Velhin, S., Braun, M., Mathey, E., Krumbholz, M., Kumpfel, T., Moldenhauer, A., Rader, C., Sonderegger, P., Pollmann, W., Tiefenthaller, C., Bauer, J., Lassmann, H., Wekerle, H., Karagogeos, D., Hohlfeld, R., Linington, C., Meinl, E.Contactin-2/TAG-1-directed autoimmunity is identified in multiple sclerosis patients and mediates gray matter pathology in animals. Proc. Nat. Acad. Sci. 106: 8302-8307, 2009. [PubMed: 19416878] [Full Text: https://doi.org/10.1073/pnas.0901496106\]
  40. Disanto, G., Magalhaes, S., Handel, A. E., Morrison, K. M., Sadovnick, A. D., Ebers, G. C., Banwell, B., Bar-Or, A., Canadian Pediatric Demyelinating Disease Network.HLA-DRB1 confers increased risk of pediatric-onset MS in children with acquired demyelination. Neurology 76: 781-786, 2011. [PubMed: 21288988] [Full Text: https://doi.org/10.1212/WNL.0b013e31820ee1cd\]
  41. Dyment, D. A., Sadnovich, A. D., Ebers, G. C.Genetics of multiple sclerosis. Hum. Molec. Genet. 6: 1693-1698, 1997. Note: Erratum: Hum. Molec. Genet. 6: 2189 only, 1997. [PubMed: 9300661] [Full Text: https://doi.org/10.1093/hmg/6.10.1693\]
  42. Dyment, D. A., Sadovnick, A. D., Willer, C. J., Armstrong, H., Cader, Z. M., Wiltshire, S., Kalman, B., Risch, N., Ebers, G. C.An extended genome scan in 442 Canadian multiple sclerosis-affected sibships: a report from the Canadian Collaborative Study Group. Hum. Molec. Genet. 13: 1005-1015, 2004. [PubMed: 15069025] [Full Text: https://doi.org/10.1093/hmg/ddh123\]
  43. Dyment, D. A., Willer, C. J., Scott, B., Armstrong, H., Ligers, A., Hillert, J., Paty, D. W., Hashimoto, S., Devonshire, V., Hooge, J., Kastrukoff, L., Oger, J., and 24 others.Genetic susceptibility to MS: a second stage analysis in Canadian MS families. Neurogenetics 3: 145-151, 2001. [PubMed: 11523565] [Full Text: https://doi.org/10.1007/s100480100113\]
  44. Ebers, G. C., Bulman, D. E., Sadovnick, A. D., Paty, D. W., Warren, S., Hader, W., Murray, T. J., Seland, T. P., Duquette, P., Grey, T., Nelson, R., Nicolle, M., Brunet, D.A population-based study of multiple sclerosis in twins. New Eng. J. Med. 315: 1638-1642, 1986. [PubMed: 3785335] [Full Text: https://doi.org/10.1056/NEJM198612253152603\]
  45. Ebers, G. C., Cousin, H. K., Feasby, T. E., Paty, D. W.Optic neuritis in familial MS. Neurology 31: 1138-1142, 1981. [PubMed: 7196536] [Full Text: https://doi.org/10.1212/wnl.31.9.1138\]
  46. Ebers, G. C., Kukay, K., Bulman, D. E., Sadovnick, A. D., Rice, G., Anderson, C., Armstrong, H., Cousin, K., Bell, R. B., Hader, W., Paty, D. W., Hashimoto, S., Oger, J., Duquette, P., Warren, S., Gray, T., O'Connor, P., Nath, A., Auty, A., Metz, L., and 10 others.A full genome search in multiple sclerosis. Nature Genet. 13: 472-476, 1996. [PubMed: 8696345] [Full Text: https://doi.org/10.1038/ng0896-472\]
  47. Ebers, G. C., Sadovnick, A. D., Risch, N. J., Canadian Collaborative Study Group.A genetic basis for familial aggregation in multiple sclerosis. Nature 377: 150-151, 1995. [PubMed: 7675080] [Full Text: https://doi.org/10.1038/377150a0\]
  48. Ebers, G. C.Personal Communication. London, Ontario, Canada 8/29/1988.
  49. Ekbom, K. A.Familial multiple sclerosis associated with narcolepsy. Arch. Neurol. 15: 337-344, 1966. [PubMed: 5912493] [Full Text: https://doi.org/10.1001/archneur.1966.00470160003001\]
  50. Enzinger, C., Ropele, S., Strasser-Fuchs, S., Kapeller, P., Schmidt, H., Poltrum, B., Schmidt, R., Hartung, H.-P., Fazekas, F.Lower levels of N-acetylaspartate in multiple sclerosis patients with the apolipoprotein E epsilon-4 allele. Arch. Neurol. 60: 65-70, 2003. [PubMed: 12533090] [Full Text: https://doi.org/10.1001/archneur.60.1.65\]
  51. Eoli, M., Pandolfo, M., Milanese, C., Gasparini, P., Salmaggi, A., Zeviani, M.The myelin basic protein gene is not a major susceptibility locus for multiple sclerosis in Italian patients. J. Neurol. 241: 615-619, 1994. [PubMed: 7530769] [Full Text: https://doi.org/10.1007/BF00920626\]
  52. Eoli, M., Wood, N. W., Kellar-Wood, H. F., Holmans, P., Clayton, D., Compston, D. A. S.No linkage between multiple sclerosis and the T cell receptor alpha chain locus. J. Neurol. Sci. 124: 32-37, 1994. [PubMed: 7931419] [Full Text: https://doi.org/10.1016/0022-510x(94)90007-8\]
  53. Fazekas, F., Strasser-Fuchs, S., Kollegger, H., Berger, T., Kristoferitsch, W., Schmidt, H., Enzinger, C., Schiefermeier, M., Schwarz, C., Kornek, B., Reindl, M., Huber, K., Grass, R., Wimmer, G., Vass, K., Pfeiffer, K. H., Hartung, H. P., Schmidt, R.Apolipoprotein E epsilon4 is associated with rapid progression of multiple sclerosis. Neurology 57: 853-857, 2001. [PubMed: 11552016] [Full Text: https://doi.org/10.1212/wnl.57.5.853\]
  54. Fernandez-Arquero, M., Arroyo, R., Rubio, A., Martin, C., Vigil, P., Conejero, L., Figueredo, M. A., de la Concha, E. G.Primary association of a TNF gene polymorphism with susceptibility to multiple sclerosis. Neurology 53: 1361-1363, 1999. [PubMed: 10522904] [Full Text: https://doi.org/10.1212/wnl.53.6.1361\]
  55. Francis, D. A., Batchelor, J. R., McDonald, W. I., Dodi, I. A., Hing, S. N., Hern, J. E. C., Downie, A. W.HLA genetic determinants in familial MS: a study from the Grampian region of Scotland. Tissue Antigens 29: 7-12, 1987. [PubMed: 3590146]
  56. Friese, M. A., Jakobsen, K. B., Friis, L., Etzensperger, R., Craner, M. J., McMahon, R. M., Jensen, L. T., Huygelen, V., Jones, E. Y., Bell, J. I., Fugger, L.Opposing effects of HLA class I molecules in tuning autoreactive CD8+ T cells in multiple sclerosis. Nature Med. 14: 1227-1235, 2008. [PubMed: 18953350] [Full Text: https://doi.org/10.1038/nm.1881\]
  57. Gaiser, C. N., Johnson, M. J., de Lange, G., Rassenti, L., Cavalli-Sforza, L. L., Steinman, L.Susceptibility to multiple sclerosis associated with an immunoglobulin gamma 3 restriction fragment length polymorphism. J. Clin. Invest. 79: 309-313, 1987. [PubMed: 2878940] [Full Text: https://doi.org/10.1172/JCI112801\]
  58. Gandhi, K. S., McKay, F. C., Cox, M., Riveros, C., Armstrong, N., Heard, R. N., Vucic, S., Williams, D. W., Stankovich, J., Brown, M., Danoy, P., Stewart, G. J., Broadley, S., Moscato, P., Lechner-Scott, J., Scott, R. J., Booth, D. R., ANZgene Multiple Sclerosis Genetics Consortium.The multiple sclerosis whole blood mRNA transcriptome and genetic associations indicate dysregulation of specific T cell pathways in pathogenesis. Hum. Molec. Genet. 19: 2134-2143, 2010. [PubMed: 20190274] [Full Text: https://doi.org/10.1093/hmg/ddq090\]
  59. Ghaffar, O., Reis, M., Pennell, N., O'Connor, P., Feinstein, A.APOE epsilon-4 and the cognitive genetics of multiple sclerosis. Neurology 74: 1611-1618, 2010. [PubMed: 20479360] [Full Text: https://doi.org/10.1212/WNL.0b013e3181e074a7\]
  60. Ghosh, S., Goldin, E., Gordon, F. H., Malchow, H. A., Rask-Madsen, J., Rutgeerts, P., Vyhnalek, P., Zadorova, Z., Palmer, T., Donoghue, S.Natalizumab for active Crohn's disease. New Eng. J. Med. 348: 24-32, 2003. [PubMed: 12510039] [Full Text: https://doi.org/10.1056/NEJMoa020732\]
  61. Goris, A., Maranian, M., Walton, A., Yeo, T. W., Ban, M., Gray, J., Dubois, B., Compston, A., Sawcer, S.CD24 Ala/Val polymorphism and multiple sclerosis. J. Neuroimmun. 175: 200-202, 2006. [PubMed: 16631259] [Full Text: https://doi.org/10.1016/j.jneuroim.2006.03.009\]
  62. Gregersen, J. W., Kranc, K. R., Ke, X., Svendsen, P., Madsen, L. S., Thomsen, A. R., Cardon, L. R., Bell, J. I., Fugger, L.Functional epistasis on a common MHC haplotype associated with multiple sclerosis. Nature 443: 574-577, 2006. [PubMed: 17006452] [Full Text: https://doi.org/10.1038/nature05133\]
  63. Haile, R. W., Hodge, S. E., Visscher, B. R., Spence, M. A., Detels, R., McAuliffe, T. L., Park, M. S., Dudley, J. P.Genetic susceptibility to multiple sclerosis: a linkage analysis with age-of-onset corrections. Clin. Genet. 18: 160-167, 1980. [PubMed: 7438496] [Full Text: https://doi.org/10.1111/j.1399-0004.1980.tb00864.x\]
  64. Haines, J. L., Bradford, Y., Garcia, M. E., Reed, A. D., Neumeister, E., Pericak-Vance, M. A., Rimmler, J. B., Menold, M. M., Martin, E. R., Oksenberg, J. R., Barcellos, L. F., Lincoln, R., Hauser, S. L.Multiple susceptibility loci for multiple sclerosis. Hum. Molec. Genet. 11: 2251-2256, 2002. [PubMed: 12217953] [Full Text: https://doi.org/10.1093/hmg/11.19.2251\]
  65. Haines, J. L., Terwedow, H. A., Burgess, K., Pericak-Vance, M. A., Rimmler, J. B., Martin, E. R., Oksenberg, J. R., Lincoln, R., Zhang, D. Y., Banatao, D. R., Gatto, N., Goodkin, D. E., Hauser, S. L.Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. Hum. Molec. Genet. 7: 1229-1234, 1998. [PubMed: 9668163] [Full Text: https://doi.org/10.1093/hmg/7.8.1229\]
  66. Hall, J. G.Personal Communication. Seattle, Wash. 1983.
  67. Hansson, S. F., Simonsen, A. H., Zetterberg, H., Andersen, O., Haghighi, S., Fagerberg, I., Andreasson, U., Westman-Brinkmalm, A., Wallin, A., Ruetschi, U., Blennow, K.Cystatin C in cerebrospinal fluid and multiple sclerosis. Ann. Neurol. 62: 193-196, 2007. [PubMed: 16900522] [Full Text: https://doi.org/10.1002/ana.20945\]
  68. He, B., Giedraitis, V., Ligers, A., Binzer, M., Andersen, P. M., Forsgren, L., Sandkuijl, L. A., Hillert, J.Sharing of a conserved haplotype suggests a susceptibility gene for multiple sclerosis at chromosome 17p11. Europ. J. Hum. Genet. 10: 271-275, 2002. [PubMed: 12032736] [Full Text: https://doi.org/10.1038/sj.ejhg.5200802\]
  69. Herrera, B. M., Ramagopalan, S. V., Lincoln, M. R., Orton, S. M., Chao, M. J., Sadovnick A. D., Ebers, G. C.Parent-of-origin effects in MS: observations from avuncular pairs. Neurology 71: 799-803, 2008. [PubMed: 18480463] [Full Text: https://doi.org/10.1212/01.wnl.0000312377.50395.00\]
  70. Hla, T., Brinkmann, V.Sphingosine 1-phosphate (S1P): physiology and the effects of S1P receptor modulation. Neurology 76 (suppl. 3): S3-S8, 2011. [PubMed: 21339489] [Full Text: https://doi.org/10.1212/WNL.0b013e31820d5ec1\]
  71. Hoffmann, S., Cepok, S., Grummel, V., Lehmann-Horn, K., Hackermuller, J., Stadler, P. F., Hartung, H.-P., Berthele, A., Deisenhammer, F., Wassmuth, R., Hemmer, B.HLA-DRB1*0401 and HLA-DRB1*0408 are strongly associated with the development of antibodies against interferon-beta therapy in multiple sclerosis. Am. J. Hum. Genet. 83: 219-227, 2008. Note: Erratum: Am. J. Hum. Genet. 83: 541 only, 2008. [PubMed: 18656179] [Full Text: https://doi.org/10.1016/j.ajhg.2008.07.006\]
  72. International Multiple Sclerosis Genetics Consortium, Wellcome Trust Case Control Consortium 2.Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476: 214-219, 2011. [PubMed: 21833088] [Full Text: https://doi.org/10.1038/nature10251\]
  73. International Multiple Sclerosis Genetics Consortium.A second major histocompatibility complex susceptibility locus for multiple sclerosis. Ann. Neurol. 61: 228-236, 2007. [PubMed: 17252545] [Full Text: https://doi.org/10.1002/ana.21063\]
  74. International Multiple Sclerosis Genetics Consortium.Risk alleles for multiple sclerosis identified by a genomewide study. New Eng. J. Med. 357: 851-862, 2007. [PubMed: 17660530] [Full Text: https://doi.org/10.1056/NEJMoa073493\]
  75. International Multiple Sclerosis Genetics Consortium.Comprehensive follow-up of the first genome-wide association study of multiple sclerosis identifies KIF21B and TMEM39A as susceptibility loci. Hum. Molec. Genet. 19: 953-962, 2010. [PubMed: 20007504] [Full Text: https://doi.org/10.1093/hmg/ddp542\]
  76. Irani, D. N., Anderson, C., Gundry, R., Cotter, R., Moore, S., Kerr, D. A., McArthur, J. C., Sacktor, N., Pardo, C. A., Jones, M., Calabresi, P. A., Nath, A.Cleavage of cystatin C in the cerebrospinal fluid of patients with multiple sclerosis. Ann. Neurol. 59: 237-247, 2006. [PubMed: 16437581] [Full Text: https://doi.org/10.1002/ana.20786\]
  77. Islam, T., Gauderman, W. J., Cozen, W., Mack, T. M.Childhood sun exposure influences risk of multiple sclerosis in monozygotic twins. Neurology 69: 381-388, 2007. [PubMed: 17646631] [Full Text: https://doi.org/10.1212/01.wnl.0000268266.50850.48\]
  78. Jacobsen, M., Schweer, D., Ziegler, A., Gaber, R., Schock, S., Schwinzer, R., Wonigeit, K., Lindert, R.-B., Kantarci, O., Schaefer-Klein, J., Schipper, H. I., Oertel, W. H., Heidenreich, F., Weinshenker, B. G., Sommer, N., Hemmer, B.A point mutation in PTPRC is associated with the development of multiple sclerosis. Nature Genet. 26: 495-499, 2000. [PubMed: 11101853] [Full Text: https://doi.org/10.1038/82659\]
  79. Jakkula, E., Leppa, V., Sulonen, A.-M., Varilo, T., Kallio, S., Kemppinen, A., Purcell, S., Koivisto, K., Tienari, P., Sumelahti, M.-L., Elovaara, I., Pirttila, T., and 17 others.Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene. Am. J. Hum. Genet. 86: 285-291, 2010. [PubMed: 20159113] [Full Text: https://doi.org/10.1016/j.ajhg.2010.01.017\]
  80. John, G. R., Shankar, S. L., Shafit-Zagardo, B., Massimi, A., Lee, S. C., Raine, C. S., Brosnan, C. F.Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation. Nature Med. 8: 1115-1121, 2002. [PubMed: 12357247] [Full Text: https://doi.org/10.1038/nm781\]
  81. Kalyvas, A., David, S.Cytosolic phospholipase A2 plays a key role in the pathogenesis of multiple sclerosis-like disease. Neuron 41: 323-335, 2004. [PubMed: 14766173] [Full Text: https://doi.org/10.1016/s0896-6273(04)00003-0\]
  82. Kantarci, O. H., Hebrink, D. D., Achenbach, S. J., Pittock, S. J., Altintas, A., Schaefer-Klein, J. L., Atkinson, E. J., de Andrade, M., McMurray, C. T., Rodriguez, M., Weinshenker, B. G.Association of APOE polymorphisms with disease severity in MS is limited to women. Neurology 62: 811-814, 2004. [PubMed: 15007140] [Full Text: https://doi.org/10.1212/01.wnl.0000113721.83287.83\]
  83. Kantor, R., Bakhanashvili, M., Achiron, A.A mutated CCR5 gene may have favorable prognostic implications in MS. Neurology 61: 238-240, 2003. [PubMed: 12874407] [Full Text: https://doi.org/10.1212/01.wnl.0000069921.20347.9e\]
  84. Kenealy, S. J., Babron, M.-C., Bradford, Y., Schnetz-Boutaud, N., Haines, J. L., Rimmler, J. B., Schmidt, S., Pericak-Vance, M. A., Barcellos, L. F., Lincoln, R. R., Oksenberg, J. R., Hauser, S. L., Clanet, M., Brassat, D., Edan, G., Yaouanq, J., Semana, G., Cournu-Rebeix, I., Lyon-Caen, O., Fontaine, B., American-French Multiple Sclerosis Genetics Group.A second-generation genomic screen for multiple sclerosis. Am. J. Hum. Genet. 75: 1070-1078, 2004. [PubMed: 15494893] [Full Text: https://doi.org/10.1086/426459\]
  85. Kinnunen, E., Koskenvuo, M., Kaprio, J., Aho, K.Multiple sclerosis in a nationwide series of twins. Neurology 37: 1627-1629, 1987. [PubMed: 3658169] [Full Text: https://doi.org/10.1212/wnl.37.10.1627\]
  86. Koutsis, G., Panas, M., Giogkaraki, E., Potagas, C., Karadima, G., Sfagos, C., Vassilopoulos, D.APOE epsilon-4 is associated with impaired verbal learning in patients with MS. Neurology 68: 546-549, 2007. [PubMed: 17310023] [Full Text: https://doi.org/10.1212/01.wnl.0000254468.51973.44\]
  87. Kroner, A., Mehling, M., Hemmer, B., Rieckmann, P., Toyka, K. V., Maurer, M., Wiendl, H.A PD-1 polymorphism is associated with disease progression in multiple sclerosis. Ann. Neurol. 58: 50-57, 2005. [PubMed: 15912506] [Full Text: https://doi.org/10.1002/ana.20514\]
  88. Kumpfel, T., Hoffmann, L.-A., Pellkofer, H., Pollmann, W., Feneberg, W., Hohlfeld, R., Lohse, P.Multiple sclerosis and the TNFRSF1A R92Q mutation: clinical characteristics of 21 cases. Neurology 71: 1812-1820, 2008. [PubMed: 19029521] [Full Text: https://doi.org/10.1212/01.wnl.0000335930.18776.47\]
  89. Kuokkanen, S., Sundvall, M., Terwilliger, J. D., Tienari, P. J., Wikstrom, J., Holmdahl, R., Pettersson, U., Peltonen, L.A putative vulnerability locus to multiple sclerosis maps to 5p14-p12 in a region syntenic to the murine locus Eae2. Nature Genet. 13: 477-480, 1996. [PubMed: 8696346] [Full Text: https://doi.org/10.1038/ng0896-477\]
  90. Kurtzke, J. F., Beebe, G. W., Norman, J. E., Jr.Epidemiology of multiple sclerosis in U.S. veterans: 1. Race, sex, and geographic distribution. Neurology 29: 1228-1235, 1979. [PubMed: 573402] [Full Text: https://doi.org/10.1212/wnl.29.9\_part\_1.1228\]
  91. Kurtzke, J. F., Hyllested, K.Multiple sclerosis in the Faroe Islands: I. Clinical and epidemiological features. Ann. Neurol. 5: 6-21, 1979. [PubMed: 371519] [Full Text: https://doi.org/10.1002/ana.410050104\]
  92. Lang, H. L. E., Jacobsen, H., Ikemizu, S., Andersson, C., Harlos, K., Madsen, L., Hjorth, P., Sondergaard, L., Svejgaard, A., Wucherpfennig, K., Stuart, D. I., Bell, J. I., Jones, E. Y., Fugger, L.A functional and structural basis for TCR cross-reactivity in multiple sclerosis. Nature Immun. 3: 940-943, 2002. [PubMed: 12244309] [Full Text: https://doi.org/10.1038/ni835\]
  93. Lanz, T. V., Brewer, R. C., Ho, P. P., Moon, J.-S., Jude, K. M., Fernandez, D., Fernandes, R. A., Gomez, A. M., Nadj, G.-S., Bartley, C. M., Schubert, R. D., Hawes, I. A., and 18 others.Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM. Nature 603: 321-327, 2022. [PubMed: 35073561] [Full Text: https://doi.org/10.1038/s41586-022-04432-7\]
  94. Ligers, A., Dyment, D. A., Willer, C. J., Sadovnick, A. D., Ebers, G., Risch, N., Hillert, J., Canadian Collaborative Study Groups.Evidence of linkage with HLA-DR in DRB1*15-negative families with multiple sclerosis. Am. J. Hum. Genet. 69: 900-903, 2001. [PubMed: 11519010] [Full Text: https://doi.org/10.1086/323480\]
  95. Lill, C. M., Schjeide, B.-M. M., Akkad, D. A., Blaschke, P., Winkelmann, A., Gerdes, L.-A., Hoffjan, S., Luessi, F., Dorner, T., Li, S.-C., Steinhagen-Thiessen, E., Lindenberger, U., and 10 others.Independent replication of STAT3 association with multiple sclerosis in a large German case-control sample. Neurogenetics 13: 83-86, 2012. [PubMed: 22095036] [Full Text: https://doi.org/10.1007/s10048-011-0305-6\]
  96. Lincoln, M. R., Montpetit, A., Cader, M. Z., Saarela, J., Dyment, D. A., Tiislar, M., Ferretti, V., Tienari, P. J., Sadovnick, A. D., Peltonen, L., Ebers, G. C., Hudson, T. J.A predominant role for the HLA class II region in the association of the MHC region with multiple sclerosis. Nature Genet. 37: 1108-1112, 2005. [PubMed: 16186814] [Full Text: https://doi.org/10.1038/ng1647\]
  97. Linker, R. A., Maurer, M., Gaupp, S., Martini, R., Holtmann, B., Giess, R., Rieckmann, P., Lassmann, H., Toyka, K. V., Sendtner, M., Gold, R.CNTF is a major protective factor in demyelinating CNS disease: a neurotrophic cytokine as modulator in neuroinflammation. Nature Med. 8: 620-624, 2002. [PubMed: 12042814] [Full Text: https://doi.org/10.1038/nm0602-620\]
  98. Lucotte, G., French MS Consortium.Confirmation of a gene for multiple sclerosis (MS) to chromosome region 19q13.3. Genet. Counsel. 13: 133-138, 2002. [PubMed: 12150212]
  99. MacKay, R. P., Myrianthopoulos, N. C.Multiple sclerosis in twins and their relatives: final report. Arch. Neurol. 15: 449-462, 1966. [PubMed: 5955946] [Full Text: https://doi.org/10.1001/archneur.1966.00470170003001\]
  100. Madsen, L. S., Andersson, E. C., Jansson, L., Krogsgaard, M., Andersen, C. B., Engberg, J., Strominger, J. L., Svejgaard, A., Hjorth, J. P., Holmdahl, R., Wucherpfennig, K. W., Fugger, L.A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor. Nature Genet. 23: 343-347, 1999. [PubMed: 10610182] [Full Text: https://doi.org/10.1038/15525\]
  101. Marrosu, M. G., Lai, M., Cocco, E., Loi, V., Spinicci, G., Pischedda, M. P., Massole, S., Marrosu, G., Contu, P.Genetic factors and the founder effect explain familial MS in Sardinia. Neurology 58: 283-288, 2002. [PubMed: 11805258] [Full Text: https://doi.org/10.1212/wnl.58.2.283\]
  102. Marrosu, M. G., Murru, M. R., Costa, G., Murru, R., Muntoni, F., Cucca, F.DRB1-DQA1-DQB1 loci and multiple sclerosis predisposition in the Sardinian population. Hum. Molec. Genet. 7: 1235-1237, 1998. [PubMed: 9668164] [Full Text: https://doi.org/10.1093/hmg/7.8.1235\]
  103. Marrosu, M. G., Murru, R., Murru, M. R., Costa, G., Zavattari, P., Whalen, M., Cocco, E., Mancosu, C., Schirru, L., Solla, E., Fadda, E., Melis, C., Porru, I., Rolesu, M., Cucca, F.Dissection of the HLA association with multiple sclerosis in the founder isolated population of Sardinia. Hum. Molec. Genet. 10: 2907-2916, 2001. [PubMed: 11741834] [Full Text: https://doi.org/10.1093/hmg/10.25.2907\]
  104. Martinez, A., Rubio, A., Urcelay, E., Fernandez-Arquero, M., de las Heras, V., Arroyo, R., Villoslada, P., Montalban, X., de la Concha, E. G.TNF-376A marks susceptibility to MS in the Spanish population: a replication study. Neurology 62: 809-810, 2004. [PubMed: 15007139] [Full Text: https://doi.org/10.1212/01.wnl.0000113722.93895.8b\]
  105. Mattila, K. M., Luomala, M., Lehtimaki, T., Laippala, P., Koivula, T., Elovaara, I.Interaction between ESR1 and HLA-DR2 may contribute to the development of MS in women. Neurology 56: 1246-1247, 2001. [PubMed: 11342704] [Full Text: https://doi.org/10.1212/wnl.56.9.1246\]
  106. McAlpine, D.Familial incidence and its significance. In: McAlpine, D.; Lumsden, C. E.; Acheson, E. D.: Multiple Sclerosis: A Reappraisal. Baltimore: Williams and Wilkins Co. (pub.) 1965. Pp. 61-74.
  107. McKusick, V. A.Personal Communication. Baltimore, Md. 1983.
  108. Mero, I.-L., Lorentzen, A. R., Ban, M., Smestad, C., Celius, E. G., Aarseth, J. H., Myhr, K.-M., Link, J., Hillert, J., Olsson, T., Kockum, I., Masterman, T., and 10 others.A rare variant of the TYK2 gene is confirmed to be associated with multiple sclerosis. Europ. J. Hum. Genet. 18: 502-504, 2010. [PubMed: 19888296] [Full Text: https://doi.org/10.1038/ejhg.2009.195\]
  109. Miller, D. H., Khan, O. A., Sheremata, W. A., Blumhardt, L. D., Rice, G. P. A., Libonati, M. A., Willmer-Hulme, A. J., Dalton, C. M., Miszkiel, K. A., O'Connor, P. W.A controlled trial of natalizumab for relapsing multiple sclerosis. New Eng. J. Med. 348: 15-23, 2003. [PubMed: 12510038] [Full Text: https://doi.org/10.1056/NEJMoa020696\]
  110. Multiple Sclerosis Genetics Group.A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability (sic) complex. Nature Genet. 13: 469-471, 1996. [PubMed: 8696344] [Full Text: https://doi.org/10.1038/ng0896-469\]
  111. Multiple Sclerosis Genetics Group.Clinical demographics of multiplex families with multiple sclerosis. Ann. Neurol. 43: 530-534, 1998. [PubMed: 9546337] [Full Text: https://doi.org/10.1002/ana.410430419\]
  112. Mumford, C. J., Wood, N. W., Kellar-Wood, H., Thorpe, J. W., Miller, D. H., Compston, D. A. S.The British Isles survey of multiple sclerosis in twins. Neurology 44: 11-15, 1994. [PubMed: 8290043] [Full Text: https://doi.org/10.1212/wnl.44.1.11\]
  113. Munger, K. L., Levin, L. I., Hollis, B. W., Howard, N. S., Ascherio, A.Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 296: 2832-2838, 2006. [PubMed: 17179460] [Full Text: https://doi.org/10.1001/jama.296.23.2832\]
  114. Mycko, M. P., Kwinkowski, M., Tronczynska, E., Szymanska, B., Selmaj, K. W.Multiple sclerosis: the increased frequency of the ICAM-1 exon 6 gene point mutation genetic type K469. Ann. Neurol. 44: 70-75, 1998. [PubMed: 9667594] [Full Text: https://doi.org/10.1002/ana.410440113\]
  115. Natowicz, M. R., Bejjani, B.Genetic disorders that masquerade as multiple sclerosis. Am. J. Med. Genet. 49: 149-169, 1994. [PubMed: 8116663] [Full Text: https://doi.org/10.1002/ajmg.1320490202\]
  116. Noseworthy, J. H., Lucchinetti, C., Rodriguez, M., Weinshenker, B. G.Multiple sclerosis. New Eng. J. Med. 343: 938-952, 2000. [PubMed: 11006371] [Full Text: https://doi.org/10.1056/NEJM200009283431307\]
  117. Oksenberg, J. R., Barcellos, L. F., Cree, B. A. C., Baranzini, S. E., Bugawan, T. L., Khan, O., Lincoln, R. R., Swerdlin, A., Mignot, E., Lin, L., Goodin, D., Erlich, H. A., Schmidt, S., Thomson, G., Reich, D. E., Pericak-Vance, M. A., Haines, J. L., Hauser, S. L.Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans. Am. J. Hum. Genet. 74: 160-167, 2004. [PubMed: 14669136] [Full Text: https://doi.org/10.1086/380997\]
  118. Otaegui, D., Saenz, A., Camano, P., Blazques, L., Goicoechea, M., Ruiz-Martinez, J., Olaskoaga, J., Emparanza, J. A., de Munain, A. L.CD24 V/V is an allele associated with the risk of developing multiple sclerosis in the Spanish population. Mult. Scler. 12: 511-514, 2006. [PubMed: 16900767] [Full Text: https://doi.org/10.1191/135248506ms1314sr\]
  119. Ousman, S. S., Tomooka, B. H., van Noort, J. M., Wawrousek, E. F., O'Connor, K. C., Hafler, D. A., Sobel, R. A., Robinson, W. H., Steinman, L.Protective and therapeutic role for alpha-beta-crystallin in autoimmune demyelination. Nature 448: 474-479, 2007. [PubMed: 17568699] [Full Text: https://doi.org/10.1038/nature05935\]
  120. Pericak-Vance, M. A., Rimmler, J. B., Martin, E. R., Haines, J. L., Garcia, M. E., Oksenberg, J. R., Barcellos, L. F., Lincoln, R., Goodkin, D. E., Hauser, S. L.Linkage and association analysis of chromosome 19q13 in multiple sclerosis. Neurogenetics 3: 195-201, 2001. [PubMed: 11714099] [Full Text: https://doi.org/10.1007/s100480100119\]
  121. Perini, P., Tagliaferri, C., Belloni, M., Biasi, G., Gallo, P.The HLA-DR13 haplotype is associated with 'benign' multiple sclerosis in northeast Italy. Neurology 57: 158-159, 2001. [PubMed: 11445652] [Full Text: https://doi.org/10.1212/wnl.57.1.158\]
  122. Pugliatti, M., Solinas, G., Sotgiu, S., Castiglia, P., Rosati, G.Multiple sclerosis distribution in northern Sardinia: spatial cluster analysis of prevalence. Neurology 58: 277-282, 2002. [PubMed: 11805257] [Full Text: https://doi.org/10.1212/wnl.58.2.277\]
  123. Raj, T., Rothamel, K., Mostafavi, S., Ye, C., Lee, M. N., Replogle, J. M., Feng, T., Lee, M., Asinovski, N., Frohlich, I., Imboywa, S., Von Korff, A., and 15 others.Polarization of the effects of autoimmune and neurodegenerative risk alleles in leukocytes. Science 344: 519-523, 2014. [PubMed: 24786080] [Full Text: https://doi.org/10.1126/science.1249547\]
  124. Ramagopalan, S. V., Dyment, D. A., Cader, M. Z., Morrison, K. M., Disanto, G., Morahan, J. M., Berlanga-Taylor, A. J., Handel, A., De Luca, G. C., Sadovnick, A. D., Lepage, P., Montpetit, A., Ebers, G. C.Rare variants in the CYP27B1 gene are associated with multiple sclerosis. Ann. Neurol. 70: 881-886, 2011. [PubMed: 22190362] [Full Text: https://doi.org/10.1002/ana.22678\]
  125. Ramagopalan, S. V., Hanwell, H. E. C., Giovannoni, G., Knappskog, P. M., Nyland, H. I., Myhr, K.-M., Ebers, G. C., Torkildsen, O.Vitamin D-dependent rickets, HLA-DRB1, and the risk of multiple sclerosis. Arch. Neurol. 67: 1034-1035, 2010. [PubMed: 20697062] [Full Text: https://doi.org/10.1001/archneurol.2010.182\]
  126. Ramagopalan, S. V., Maugeri, N. J., Handunnetthi, L., Lincoln, M. R., Orton, S.-M., Dyment, D. A., DeLuca, G. C., Herrera, B. M., Chao, M. J., Sadovnick, A. D., Ebers, G. C., Knight, J. C.Expression of the multiple sclerosis-associated MHC class II allele HLA-DRB1*1501 is regulated by vitamin D. PLoS Genet. 5: e1000369, 2009. Note: Electronic Article. [PubMed: 19197344] [Full Text: https://doi.org/10.1371/journal.pgen.1000369\]
  127. Reich, D., Patterson, N., De Jager, P. L., McDonald, G. J., Waliszewska, A., Tandon, A., Lincoln, R. R., DeLoa, C., Fruhan, S. A., Cabre, P., Bera, O., Semana, G., Kelly, M. A., Francis, D. A., Ardlie, K., Khan, O., Cree, B. A. C., Hauser, S. L., Oksenberg, J. R., Hafler, D. A.A whole-genome admixture scan finds a candidate locus for multiple sclerosis susceptibility. Nature Genet. 37: 1113-1118, 2005. [PubMed: 16186815] [Full Text: https://doi.org/10.1038/ng1646\]
  128. Rife, D. C.Populations of hybrid origin as source material for the detection of linkage. Am. J. Hum. Genet. 6: 26-33, 1954. [PubMed: 13138567]
  129. Ristori, G., Cannoni, S., Stazi, M. A., Vanacore, N., Cotichini, R., Alfo, M., Pugliatti, M., Sotgiu, S., Solaro, C., Bomprezzi, R., Di Giovanni, S., Talamanca, L. F., and 10 others.Multiple sclerosis in twins from continental Italy and Sardinia: a nationwide study. Ann. Neurol. 59: 27-34, 2006. [PubMed: 16240370] [Full Text: https://doi.org/10.1002/ana.20683\]
  130. Rose, J., Gerken, S., Lynch, S., Pisani, P., Varvil, T., Otterud, B., Leppert, M.Genetic susceptibility in familial multiple sclerosis not linked to the myelin basic protein gene. Lancet 341: 1179-1181, 1993. [PubMed: 7683738] [Full Text: https://doi.org/10.1016/0140-6736(93)91003-5\]
  131. Saarela, J., Schoenberg Fejzo, M., Chen, D., Finnila, S., Parkkonen, M., Kuokkanen, S., Sobel, E., Tienari, P. J., Sumelahti, M.-L., Wikstrom, J., Elovaara, I., Koivisto, K., Pirttila, T., Reunanen, M., Palotie, A., Peltonen, L.Fine mapping of a multiple sclerosis locus to 2.5 Mb on chromosome 17q22-q24. Hum. Molec. Genet. 11: 2257-2267, 2002. [PubMed: 12217954] [Full Text: https://doi.org/10.1093/hmg/11.19.2257\]
  132. Sadovnick, A. D., Dircks, A., Ebers, G. C.Genetic counselling in multiple sclerosis: risks to sibs and children of affected individuals. Clin. Genet. 56: 118-122, 1999. [PubMed: 10517247] [Full Text: https://doi.org/10.1034/j.1399-0004.1999.560204.x\]
  133. Sadovnick, A. D., Ebers, G. C., Dyment, D. A., Risch, N. J., Canadian Collaborative Study Group.Evidence for genetic basis of multiple sclerosis. Lancet 347: 1728-1730, 1996. [PubMed: 8656905] [Full Text: https://doi.org/10.1016/s0140-6736(96)90807-7\]
  134. Sadovnick, A. D., Macleod, P. M. J.The familial nature of multiple sclerosis: empiric recurrence risks for first-, second-, and third-degree relatives of patients. Neurology 31: 1039-1041, 1981. [PubMed: 7196517] [Full Text: https://doi.org/10.1212/wnl.31.8.1039\]
  135. Sadovnick, A. D., Spence, M. A., Tideman, S.A goodness-of-fit test for the polygenic threshold model: application to multiple sclerosis. Am. J. Med. Genet. 8: 355-361, 1981. [PubMed: 7234906] [Full Text: https://doi.org/10.1002/ajmg.1320080315\]
  136. Salier, J.-P., Sesboue, R., Martin-Mondiere, C., Daveau, M., Cesaro, P., Cavelier, B., Coquerel, A., Legrand, L., Goust, J. M., Degos, J. D.Combined influences of Gm and HLA phenotypes upon multiple sclerosis susceptibility and severity. J. Clin. Invest. 78: 533-538, 1986. [PubMed: 3461005] [Full Text: https://doi.org/10.1172/JCI112605\]
  137. Sawcer, S., Ban, M., Wason, J., Dudbridge, F.What role for genetics in the prediction of multiple sclerosis? Ann. Neurol. 67: 3-10, 2010. [PubMed: 20186855] [Full Text: https://doi.org/10.1002/ana.21911\]
  138. Sawcer, S., Jones, H. B., Feakes, R., Gray, J., Smaldon, N., Chataway, J., Robertson, N., Clayton, D., Goodfellow, P. N., Compston, A.A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nature Genet. 13: 464-468, 1996. [PubMed: 8696343] [Full Text: https://doi.org/10.1038/ng0896-464\]
  139. Schmidt, S., Barcellos, L. F., DeSombre, K., Rimmler, J. B., Lincoln, R. R., Bucher, P., Saunders, A. M., Lai, E., Martin, E. R., Vance, J. M., Oksenberg, J. R., Hauser, S. L., Pericak-Vance, M. A., Haines, J. L., Multiple Sclerosis Genetics Group.Association of polymorphisms in the apolipoprotein E region with susceptibility to and progression of multiple sclerosis. Am. J. Hum. Genet. 70: 708-717, 2002. [PubMed: 11836653] [Full Text: https://doi.org/10.1086/339269\]
  140. Schrijver, H. M., Crusius, J. B. A., Uitdehaag, B. M. J., Garcia Gonzalez, M. A., Kostense, P. J., Polman, C. H., Pena, A. S.Association of interleukin-1-beta and interleukin-1 receptor antagonist genes with disease severity in MS. Neurology 52: 595-599, 1999. [PubMed: 10025794] [Full Text: https://doi.org/10.1212/wnl.52.3.595\]
  141. Seboun, E., Robinson, M. A., Doolittle, T. H., Ciulla, T. A., Kindt, T. J., Hauser, S. L.A susceptibility locus for multiple sclerosis is linked to the T cell receptor beta chain complex. Cell 57: 1095-1100, 1989. [PubMed: 2567636] [Full Text: https://doi.org/10.1016/0092-8674(89)90046-9\]
  142. Sharief, M. K., Semra, Y. K.Down-regulation of survivin expression in T lymphocytes after interferon beta-1a treatment in patients with multiple sclerosis. Arch. Neurol. 59: 1115-1121, 2002. [PubMed: 12117359] [Full Text: https://doi.org/10.1001/archneur.59.7.1115\]
  143. Sheremata, W. A., Poskanzer, D. C., Withum, D. G., MacLeod, C. L., Whiteside, M. E.Unusual occurrence on a tropical island of multiple sclerosis. Lancet 325: 618 only, 1985. Note: Originally Volume II. [PubMed: 2863628] [Full Text: https://doi.org/10.1016/s0140-6736(85)90621-x\]
  144. Soliven, B., Miron, V., Chun, J.The neurobiology of sphingosine 1-phosphate signaling and sphingosine 1-phosphate receptor modulators. Neurology 76 (suppl. 3): S9-S14, 2011. [PubMed: 21339490] [Full Text: https://doi.org/10.1212/WNL.0b013e31820d9507\]
  145. Srivastava, R., Aslam, M., Kalluri, S. R., Schirmer, L., Buck, D., Tackenberg, B., Rothhammer, V., Chan, A., Gold, R., Berthele, A., Bennett, J. L., Korn, T., Hemmer, B.Potassium channel KIR4.1 as an immune target in multiple sclerosis. New Eng. J. Med. 367: 115-123, 2012. [PubMed: 22784115] [Full Text: https://doi.org/10.1056/NEJMoa1110740\]
  146. Steinman, L.Presenting an odd autoantigen. Nature 375: 739-740, 1995. [PubMed: 7541112] [Full Text: https://doi.org/10.1038/375739b0\]
  147. Steinman, L.Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell 85: 299-302, 1996. [PubMed: 8616884] [Full Text: https://doi.org/10.1016/s0092-8674(00)81107-1\]
  148. Svejgaard, A.The immunogenetics of multiple sclerosis. Immunogenetics 60: 275-286, 2008. [PubMed: 18461312] [Full Text: https://doi.org/10.1007/s00251-008-0295-1\]
  149. Szvetko, A. L., Jones, A., Mackenzie, J., Tajouri, L., Csurhes, P. A., Greer, J. M., Pender, M. P., Griffiths, L. R.An investigation of the C77G and C772T variations within the human protein tyrosine phosphatase receptor type C gene for association with multiple sclerosis in an Australian population. Brain Res. 1255: 148-152, 2009. [PubMed: 19111528] [Full Text: https://doi.org/10.1016/j.brainres.2008.12.017\]
  150. Takahashi, J. L., Giuliani, F., Power, C., Imai, Y., Yong, V. W.Interleukin-1-beta promotes oligodendrocyte death through glutamate excitotoxicity. Ann. Neurol. 53: 588-595, 2003. [PubMed: 12730992] [Full Text: https://doi.org/10.1002/ana.10519\]
  151. Tan, Y.-V., Abad, C., Lopez, R., Dong, H., Liu, S., Lee, A., Gomariz, R. P., Leceta, J., Waschek, J. A.Pituitary adenylyl cyclase-activating polypeptide is an intrinsic regulator of Treg abundance and protects against experimental autoimmune encephalomyelitis. Proc. Nat. Acad. Sci. 106: 2012-2017, 2009. [PubMed: 19190179] [Full Text: https://doi.org/10.1073/pnas.0812257106\]
  152. Terasaki, P. I., Park, M. S., Opelz, G., Ting, A.Multiple sclerosis and high incidence of a B-lymphocyte antigen. Science 193: 1245-1247, 1976. [PubMed: 1085490] [Full Text: https://doi.org/10.1126/science.1085490\]
  153. Tienari, P. J., Peltonen, L., Palo, J.Genetic susceptibility to multiple sclerosis linked to myelin basic protein gene. Reply. (Letter) Lancet 341: 56, 1993.
  154. Tienari, P. J., Terwilliger, J. D., Ott, J., Palo, J., Peltonen, L.Two-locus linkage analysis in multiple sclerosis (MS). Genomics 19: 320-325, 1994. [PubMed: 7514567] [Full Text: https://doi.org/10.1006/geno.1994.1064\]
  155. Tienari, P. J., Wikstrom, J., Sajantila, A., Palo, J., Peltonen, L.Genetic susceptibility to multiple sclerosis linked to myelin basic protein gene. Lancet 340: 987-991, 1992. [PubMed: 1383661] [Full Text: https://doi.org/10.1016/0140-6736(92)93007-a\]
  156. Tiwari, J. L., Hodge, S. E., Terasaki, P. I., Spence, M. A.HLA and the inheritance of multiple sclerosis: linkage analysis of 72 pedigrees. Am. J. Hum. Genet. 32: 103-111, 1980. [PubMed: 7361760]
  157. Torkildsen, O., Knappskog, P. M., Nyland, H. I., Myhr, K.-M.Vitamin D-dependent rickets as a possible risk factor for multiple sclerosis. Arch. Neurol. 65: 809-811, 2008. [PubMed: 18541802] [Full Text: https://doi.org/10.1001/archneur.65.6.809\]
  158. Utz, U., Biddison, W. E., McFarland, H. F., McFarlin, D. E., Flerlage, M., Martin, R.Skewed T-cell receptor repertoire in genetically identical twins correlates with multiple sclerosis. Nature 364: 243-247, 1993. [PubMed: 7686632] [Full Text: https://doi.org/10.1038/364243a0\]
  159. van der Walt, A., Stankovich, J., Bahlo, M., Taylor, B. V., van der Mei, I. A. F., Foote, S. J., Kilpatrick, T. J., Rubio, J. P., Butzkueven, H.Apolipoprotein genotype does not influence MS severity, cognition, or brain atrophy. Neurology 73: 1018-1025, 2009. [PubMed: 19786693] [Full Text: https://doi.org/10.1212/WNL.0b013e3181b9c85e\]
  160. van Noort, J. M., van Sechel, A. C., Bajramovic, J. J., El Quagmiri, M., Polman, C. H., Lassmann, H., Ravid, R.The small heat-shock protein alpha-B-crystallin as candidate autoantigen in multiple sclerosis. Nature 375: 798-801, 1995. [PubMed: 7596414] [Full Text: https://doi.org/10.1038/375798a0\]
  161. Vandenbroeck, K., Opdenakker, G., Goris, A., Murru, R., Billiau, A., Marrosu, M. G.Interferon-gamma gene polymorphism--associated risk for multiple sclerosis in Sardinia. Ann. Neurol. 44: 841-842, 1998. [PubMed: 9818947] [Full Text: https://doi.org/10.1002/ana.410440525\]
  162. Vitale, E., Cook, S., Sun, R., Specchia, C., Subramanian, K., Rocchi, M., Nathanson, D., Schwalb, M., Devoto, M., Rohowsky-Kochan, C.Linkage analysis conditional on HLA status in a large North American pedigree supports the presence of a multiple sclerosis susceptibility locus on chromosome 12p12. Hum. Molec. Genet. 11: 295-300, 2002. [PubMed: 11823448] [Full Text: https://doi.org/10.1093/hmg/11.3.295\]
  163. von Andrian, U. H., Engelhardt, B.Alpha-4 integrins as therapeutic targets in autoimmune disease. (Editorial) New Eng. J. Med. 348: 68-72, 2003. [PubMed: 12510047] [Full Text: https://doi.org/10.1056/NEJMe020157\]
  164. Vorechovsky, I., Kralovicova, J., Tchilian, E., Masterman, T., Zhang, Z., Ferry, B., Misbah, S., Chapel, H., Webster, D., Hellgren, D., Anvret, M., Hillert, J., Hammarstrom, L., Beverley, P. C.Does 77C-G in PTPRC modify autoimmune disorders linked to the major histocompatibility locus? Nature Genet. 29: 22-23, 2001. [PubMed: 11548742] [Full Text: https://doi.org/10.1038/ng723\]
  165. Vyse, T. J., Todd, J. A.Genetic analysis of autoimmune disease. Cell 85: 311-318, 1996. [PubMed: 8616887] [Full Text: https://doi.org/10.1016/s0092-8674(00)81110-1\]
  166. Waksman, B. H.More genes versus environment. Nature 377: 105-106, 1995. [PubMed: 7675076] [Full Text: https://doi.org/10.1038/377105a0\]
  167. Wallin, M. T., Page, W. F., Kurtzke, J. F.Multiple sclerosis in US veterans of the Vietnam era and later military service: race, sex, and geography. Ann. Neurol. 55: 65-71, 2004. [PubMed: 14705113] [Full Text: https://doi.org/10.1002/ana.10788\]
  168. Walter, M. A., Gibson, W. T., Ebers, G. C., Cox, D. W.Susceptibility to multiple sclerosis is associated with the proximal immunoglobulin heavy chain variable region. J. Clin. Invest. 87: 1266-1273, 1991. [PubMed: 1672695] [Full Text: https://doi.org/10.1172/JCI115128\]
  169. Weinshenker, B. G., Hebrink, D. D., Atkinson, E., Kantarci, O. H.Association of a tumor necrosis factor alpha polymorphism with MS susceptibility. Neurology 57: 1341-1346, 2001. [PubMed: 11591866] [Full Text: https://doi.org/10.1212/wnl.57.7.1341\]
  170. Weinshenker, B. G., Kantarci, O. H.Association of APOE polymorphisms with disease severity in MS is limited to women. (Letter) Neurology 63: 1139 only, 2004.
  171. Wellcome Trust Case Control Consortium and The Australo-Anglo-American Spondylitis Consortium.Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nature Genet. 39: 1329-1337, 2007. [PubMed: 17952073] [Full Text: https://doi.org/10.1038/ng.2007.17\]
  172. Wheeler, D., Jelinek, C., Anderson, C., Gundry, R., Irani, D., Calbresi, P., Cotter, R., Nath, A.Reply. Ann. Neurol. 62: 205 only, 2007.
  173. Willer, C. J., Dyment, D. A., Risch, N. J., Sadovnick, A. D., Ebers, G. C., The Canadian Collaborative Study Group.Twin concordance and sibling recurrence rates in multiple sclerosis. Proc. Nat. Acad. Sci. 100: 12877-12882, 2003. [PubMed: 14569025] [Full Text: https://doi.org/10.1073/pnas.1932604100\]
  174. Willer, C. J., Dyment, D. A., Sadovnick, A. D., Rothwell, P. M., Murray, T. J., Ebers, G. C.Timing of birth and risk of multiple sclerosis: population based study. Brit. Med. J. 330: 120, 2005. Note: Electronic Article. [PubMed: 15585537] [Full Text: https://doi.org/10.1136/bmj.38301.686030.63\]
  175. Williams, A., Eldridge, R., McFarland, H., Houff, S., Krebs, H., McFarlin, D.Multiple sclerosis in twins. Neurology 30: 1139-1147, 1980. [PubMed: 7191511] [Full Text: https://doi.org/10.1212/wnl.30.11.1139\]
  176. Williams, K. E., Johnson, L. N.Neuroretinitis in patients with multiple sclerosis. Ophthalmology 111: 335-341, 2004. [PubMed: 15019385] [Full Text: https://doi.org/10.1016/S0161-6420(03)00663-8\]
  177. Wood, N. W., Holmans, P., Clayton, D., Robertson, N., Compston, D. A. S.No linkage or association between multiple sclerosis and the myelin basic protein gene in affected sibling pairs. J. Neurol. Neurosurg. Psychiat. 57: 1191-1194, 1994. [PubMed: 7523603] [Full Text: https://doi.org/10.1136/jnnp.57.10.1191\]
  178. Xu, C., Dai, Y., Lorentzen, J. C., Dahlman, I., Olsson, T., Hillert, J.Linkage analysis in multiple sclerosis of chromosomal regions syntenic to experimental autoimmune disease loci. Europ. J. Hum. Genet. 9: 458-463, 2001. [PubMed: 11436128] [Full Text: https://doi.org/10.1038/sj.ejhg.5200653\]
  179. Yang, Y., Liu, Y., Wei, P., Peng, H., Winger, R., Hussain, R. Z., Ben, L.-H., Cravens, P. D., Gocke, A. R., Puttaparthi, K., Racke, M. K., McTigue, D. M., Lovett-Racke, A. E.Silencing Nogo-A promotes functional recovery in demyelinating disease. Ann. Neurol. 67: 498-507, 2010. [PubMed: 20437585] [Full Text: https://doi.org/10.1002/ana.21935\]
  180. Youssef, S., Stuve, O., Patarroyo, J. C., Ruiz, P. J., Radosevich, J. L., Hur, E. M., Bravo, M., Mitchell, D. J., Sobel, R. A., Steinman, L., Zamvil, S. S.The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature 420: 78-84, 2002. [PubMed: 12422218] [Full Text: https://doi.org/10.1038/nature01158\]
  181. Zhou, Q., Rammohan, K., Lin, S., Robinson, N., Li, O., Liu, X., Bai, X., Yin, L., Scarberry, B., Du, P., You, M., Guan, K., Zheng, P., Liu, Y.CD24 is a genetic modifier for risk and progression of multiple sclerosis. Proc. Nat. Acad. Sci. 100: 15041-15046, 2003. Note: Erratum: Proc. Nat. Acad. Sci. 102: 8392 only, 2005. [PubMed: 14657362] [Full Text: https://doi.org/10.1073/pnas.2533866100\]
  182. Zipp, F., Weber, F., Huber, S., Sotgiu, S., Czlonkowska, A., Holler, E., Albert, E., Weiss, E. H., Wekerle, H., Hohlfeld, R.Genetic control of multiple sclerosis: increased production of lymphotoxin and tumor necrosis factor-alpha by HLA-DR2(+) T cells. Ann. Neurol. 38: 723-730, 1995. [PubMed: 7486863] [Full Text: https://doi.org/10.1002/ana.410380506\]
  183. Zwemmer, J., Uitdehaag, B., van Kamp, G., Barkhof, F., Polman, C.Association of APOE polymorphisms with disease severity in MS is limited to women. (Letter) Neurology 63: 1139 only, 2004. [PubMed: 15452327] [Full Text: https://doi.org/10.1212/wnl.63.6.1139\]